Cipla receives final USFDA nod for Lanreotide injection to treat tumours
Mumbai, May 22: Drugmaker Cipla on Wednesday announced that the US Food and Drug Administration (USFDA) has granted it final approval for the Lanreotide injection, used for the treatment of acromegaly...
Read moreDetails







